SCHEMBL17718587

SCHEMBL17718587

CC(C)(C)C/C=C\COCC(C)(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17718582 1.00 — —
SCHEMBL13141355 0.89 CYP2C19 (0.33) —
SCHEMBL25939779 0.89 CYP2C19 (0.33) —
SCHEMBL9750758 0.87 — —
SCHEMBL17722548 0.80 — —
SCHEMBL25807944 0.80 — —
SCHEMBL13302441 0.80 PTGS1 (0.37) —
SCHEMBL26537516 0.77 — —
SCHEMBL13179248 0.76 — —
SCHEMBL24741367 0.75 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160122342-A1 ENHANCER OF ZESTE HOMOLOG 2 INHIBITORS GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED (GB) 2016-05-05 — — US disclosed
US-20160122342-A1 ENHANCER OF ZESTE HOMOLOG 2 INHIBITORS GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED (GB) 2016-05-05 — — US disclosed
Send feedback